TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 97 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2015. The put-call ratio across all filers is 0.54 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $838,025 | +0.8% | 22,223 | +1.4% | 0.00% | – |
| Q2 2023 | $831,271 | +7.1% | 21,916 | +103.3% | 0.00% | – |
| Q2 2021 | $776,000 | -5.7% | 10,782 | -3.4% | 0.00% | – |
| Q1 2021 | $823,000 | -37.9% | 11,160 | -38.2% | 0.00% | – |
| Q4 2020 | $1,326,000 | +53.8% | 18,063 | +14.9% | 0.00% | – |
| Q3 2020 | $862,000 | -62.4% | 15,721 | -54.3% | 0.00% | -100.0% |
| Q2 2020 | $2,290,000 | +6.3% | 34,435 | -2.2% | 0.00% | 0.0% |
| Q1 2020 | $2,154,000 | -57.4% | 35,196 | -38.8% | 0.00% | 0.0% |
| Q4 2019 | $5,053,000 | +38.2% | 57,469 | +18.6% | 0.00% | 0.0% |
| Q3 2019 | $3,656,000 | -14.2% | 48,450 | -2.9% | 0.00% | 0.0% |
| Q2 2019 | $4,263,000 | -15.7% | 49,909 | +6.6% | 0.00% | 0.0% |
| Q1 2019 | $5,059,000 | +4.5% | 46,801 | -18.2% | 0.00% | -50.0% |
| Q4 2018 | $4,843,000 | +60.6% | 57,216 | +86.5% | 0.00% | +100.0% |
| Q3 2018 | $3,015,000 | +29.6% | 30,676 | +52.5% | 0.00% | 0.0% |
| Q2 2018 | $2,326,000 | +102.8% | 20,109 | +73.1% | 0.00% | – |
| Q1 2018 | $1,147,000 | +85.0% | 11,617 | +96.1% | 0.00% | – |
| Q4 2017 | $620,000 | -82.0% | 5,923 | -80.6% | 0.00% | -100.0% |
| Q3 2017 | $3,438,000 | +2.0% | 30,502 | +1.5% | 0.00% | 0.0% |
| Q2 2017 | $3,369,000 | -16.7% | 30,066 | -13.3% | 0.00% | 0.0% |
| Q1 2017 | $4,044,000 | +12.5% | 34,677 | +1.6% | 0.00% | 0.0% |
| Q4 2016 | $3,594,000 | -6.1% | 34,139 | -1.4% | 0.00% | 0.0% |
| Q3 2016 | $3,828,000 | -20.6% | 34,639 | +4.5% | 0.00% | 0.0% |
| Q2 2016 | $4,824,000 | +92.3% | 33,133 | +89.2% | 0.00% | 0.0% |
| Q1 2016 | $2,508,000 | -3.9% | 17,510 | +3.7% | 0.00% | 0.0% |
| Q4 2015 | $2,611,000 | +992.5% | 16,891 | +909.0% | 0.00% | – |
| Q3 2015 | $239,000 | +13.8% | 1,674 | +14.6% | 0.00% | – |
| Q2 2015 | $210,000 | -85.6% | 1,461 | -85.9% | 0.00% | – |
| Q1 2015 | $1,459,000 | +16.8% | 10,346 | +22.7% | 0.00% | – |
| Q4 2014 | $1,249,000 | -3.7% | 8,430 | +0.0% | 0.00% | – |
| Q3 2014 | $1,297,000 | -45.1% | 8,429 | -50.0% | 0.00% | – |
| Q2 2014 | $2,364,000 | +152.6% | 16,858 | +100.0% | 0.00% | – |
| Q1 2014 | $936,000 | – | 8,429 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |